Chitosan Oligosaccharide Attenuates Nonalcoholic Fatty Liver Disease Induced by High Fat Diet through Reducing Lipid Accumulation, Inflammation and Oxidative Stress in C57BL/6 Mice

Nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease closely associated with metabolic syndrome, but there are no validated pharmacological therapies. The aim of this study was to investigate the effect of chitosan oligosaccharide (COS) on NAFLD. Mice were fed ei...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Wenjing, Sun, Wanjing, Liu, Lujie, Wang, Geng, Xiao, Zhiping, Pei, Xun, Wang, Minqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891487/
https://www.ncbi.nlm.nih.gov/pubmed/31744059
http://dx.doi.org/10.3390/md17110645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891487/
https://www.ncbi.nlm.nih.gov/pubmed/31744059
http://dx.doi.org/10.3390/md17110645

Ejemplares similares